C71T
CANCELLED SECTION 71
03/06/2026
Back to search
Official data from USPTO
CLINICREADY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
03/31/2026
Trademark type
Word
Nice classes
42
Filing date
09/13/2012
Registration date
12/17/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/06/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Darmstadt, DE
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Merck KGaA
Merck KGaA
Representatives
William C. Wright Epstein Drangel LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; industrial analysis and research services in the form of consulting services in the designdevelopmentimplementation and operation of a pharmaceutical and biotechnology drug production processes
Publications
History of USPTO decisions and trademark events.
42 publications found
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/17/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/29/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
02/04/2020
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
02/04/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/04/2020
ES75
TEAS SECTION 71 & 15 RECEIVED
12/13/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/17/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/29/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2014
FIMP
FINAL DISPOSITION PROCESSED
05/09/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2013
PUBO
PUBLISHED FOR OPPOSITION
10/01/2013
GPNX
NOTIFICATION PROCESSED BY IB
09/30/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/11/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/11/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/27/2013
ALIE
ASSIGNED TO LIE
08/26/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
08/15/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/15/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
08/15/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/15/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/09/2013
GNFR
FINAL REFUSAL E-MAILED
07/09/2013
CNFR
FINAL REFUSAL WRITTEN
07/09/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/27/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/27/2013
RFNT
REFUSAL PROCESSED BY IB
02/20/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/29/2013
RFRR
REFUSAL PROCESSED BY MPU
01/29/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/29/2013
MAFR
APPLICATION FILING RECEIPT MAILED
01/29/2013
CNRT
NON-FINAL ACTION WRITTEN
01/28/2013
DOCK
ASSIGNED TO EXAMINER
01/25/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/25/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/17/2013
Continuous trademark protection
Get notified about every new filing that threatens CLINICREADY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.